Table 1 TCT diagnosis of cervical epithelial cells in control and study groups
Pathologic diagnosis | Number | NILM | ASCUS | LSIL | HSIL | SCC |
|---|---|---|---|---|---|---|
Control group | 40 | 37 (92.5) | 3 (7.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Study group | 151 | |||||
CIN I | 27 | 2 (7.4) | 7 (25.9) | 11 (40.8) | 7 (25.9) | 0 (0.0) |
CIN II/III | 54 | 0 (0.0) | 7 (12.9) | 21 (38.9) | 26 (48.2) | 0 (0.0) |
Carcinoma in situ | 17 | 0 (0.0) | 4 (23.5) | 2 (11.8) | 11 (64.7) | 0 (0.0) |
Invasive Carcinoma | 28 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 28 (100.0) |
CIN LEEP post-treatment | 11 | 7 (63.6) | 4 (36.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Cervical cancer post-treatment | 14 | 7 (50.0) | 7 (50.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |